The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Merus
MRUS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$53.59
0.24
0.45%
At Close: -
$53.59
0
0.00%
After Hours: Aug 23, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Merus (MRUS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Merus (NASDAQ:MRUS) Stock
Merus Stock (NASDAQ: MRUS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, August 05, 2024
Needham Maintains Buy on Merus, Lowers Price ...
Benzinga Newsdesk
Thursday, August 01, 2024
Merus Q2 EPS $(0.81) Misses $(0.76) Estimate,...
Benzinga Newsdesk
Thursday, July 25, 2024
Canaccord Genuity Maintains Buy on Merus, Mai...
Benzinga Newsdesk
Wednesday, July 24, 2024
Merus Announced That The First Patient Has Be...
Benzinga Newsdesk
Monday, July 08, 2024
Merus N.V. Doses First Patient In Phase 2 Tri...
Benzinga Newsdesk
Friday, June 28, 2024
Needham Reiterates Buy on Merus, Maintains $9...
Benzinga Newsdesk
Wednesday, June 26, 2024
Citigroup Maintains Buy on Merus, Raises Pric...
Benzinga Newsdesk
Tuesday, June 25, 2024
B of A Securities Maintains Buy on Merus, Mai...
Benzinga Newsdesk
Monday, June 17, 2024
Stifel Maintains Buy on Merus, Raises Price T...
Benzinga Newsdesk
Wednesday, June 05, 2024
B of A Securities Maintains Buy on Merus, Low...
Benzinga Newsdesk
Tuesday, June 04, 2024
BMO Capital Maintains Outperform on Merus, Ra...
Benzinga Newsdesk
Truist Securities Maintains Buy on Merus, Rai...
Benzinga Newsdesk
Monday, June 03, 2024
Merus' MCLA-129 Demonstrates Single-Agent Eff...
Benzinga Newsdesk
Sunday, June 02, 2024
Merus Presented Interim Data On MCLA-145 Monotherapy And In Combination With Pembrolizumab At ASCO 2024
Charles Gross
Thursday, May 30, 2024
Reported Earlier, Merus Prices Upsized Public...
Benzinga Newsdesk
Wednesday, May 29, 2024
B of A Securities Maintains Buy on Merus, Rai...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Merus, R...
Benzinga Newsdesk
Tuesday, May 28, 2024
Merus Announces $300M Proposed Public Offerin...
Benzinga Newsdesk
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Needham Maintains Buy on Merus, Raises Price ...
Benzinga Newsdesk
Guggenheim Maintains Buy on Merus, Raises Pri...
Benzinga Newsdesk
Stifel Maintains Buy on Merus, Raises Price T...
Benzinga Newsdesk
Merus Reveals Interim Results for Bispecific ...
Benzinga Newsdesk
Friday, May 24, 2024
Crude Oil Rises 1%; Verastem Shares Slide
Avi Kapoor
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Vandana Singh
Nasdaq Gains 1%; Intuit Shares Plunge
Avi Kapoor
Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Market-Moving News for May 24th
Benzinga Newsdesk
Merus shares are trading higher after the com...
Benzinga Newsdesk
Reported Earlier, Merus Announces Publication...
Benzinga Newsdesk
B of A Securities Maintains Buy on Merus, Rai...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Merus, ...
Benzinga Newsdesk
Needham Reiterates Buy on Merus, Maintains $6...
Benzinga Newsdesk
Monday, May 13, 2024
Petosemtamab Receives Breakthrough Therapy De...
Benzinga Newsdesk
FDA Grants Merus Breakthrough Therapy Designa...
Benzinga Newsdesk
Needham Reiterates Buy on Merus, Maintains $6...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Merus, ...
Benzinga Newsdesk
Wednesday, May 08, 2024
Merus Q1 EPS $(0.59) Beats $(0.81) Estimate, ...
Benzinga Newsdesk
Monday, May 06, 2024
Merus Announces U.S. FDA Acceptance And Prior...
Benzinga Newsdesk
Thursday, April 11, 2024
Needham Reiterates Buy on Merus, Maintains $6...
Benzinga Newsdesk
Monday, April 08, 2024
Merus Presents Preclinical Data Demonstrating...
Benzinga Newsdesk
Thursday, March 28, 2024
Truist Securities Initiates Coverage On Merus...
Benzinga Newsdesk
Thursday, March 07, 2024
Needham Maintains Buy on Merus, Raises Price ...
Benzinga Newsdesk
Wednesday, March 06, 2024
Gilead and Merus Announce Collaboration To Di...
Benzinga Newsdesk
Tuesday, March 05, 2024
Merus Announces Publication Of Abstract For P...
Benzinga Newsdesk
Monday, March 04, 2024
Needham Maintains Buy on Merus, Raises Price ...
Benzinga Newsdesk
Thursday, February 29, 2024
On Wednesday February 28, 2024, Merus Reported Q4 Adjusted. EPS $(1.09) Misses $(0.74) Estimate, Sales $8.94M Miss $10.13M Estimate
Happy Mohamed
HC Wainwright & Co. Maintains Buy on Merus, R...
Benzinga Newsdesk
Stifel Maintains Buy on Merus, Raises Price T...
Benzinga Newsdesk
Show More